Literature DB >> 24979456

Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease.

Adeera Levin, Paul E Stevens, Josef Coresh, Andrew Levey.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24979456     DOI： 10.7326/L14-5013-2

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  3 in total

Review 1.  The next generation of therapeutics for chronic kidney disease.

Authors:  Matthew D Breyer; Katalin Susztak
Journal:  Nat Rev Drug Discov       Date:  2016-05-27       Impact factor: 84.694

Review 2.  Reducing the costs of chronic kidney disease while delivering quality health care: a call to action.

Authors:  Raymond Vanholder; Lieven Annemans; Edwina Brown; Ron Gansevoort; Judith J Gout-Zwart; Norbert Lameire; Rachael L Morton; Rainer Oberbauer; Maarten J Postma; Marcello Tonelli; Wim Van Biesen; Carmine Zoccali
Journal:  Nat Rev Nephrol       Date:  2017-05-30       Impact factor: 28.314

3.  Prevalence and determinants of chronic kidney disease in northeast of Iran: Results of the Golestan cohort study.

Authors:  Sadaf G Sepanlou; Hamid Barahimi; Iraj Najafi; Farin Kamangar; Hossein Poustchi; Ramin Shakeri; Monir Sadat Hakemi; Akram Pourshams; Masoud Khoshnia; Abdolsamad Gharravi; Behrooz Broumand; Ali Nobakht-Haghighi; Kamyar Kalantar-Zadeh; Reza Malekzadeh
Journal:  PLoS One       Date:  2017-05-03       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.